News Revelation Biosciences, Inc.

Equities

REVB

US76135L5075

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-10 pm EDT			5-day change	1st Jan Change
2.06 ^USD	-6.36%		-13.08%	-86.29%

Mar. 22	Revelation Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Mar. 22	Revelation Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024	May. 10	BU
Revelation Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 22	CI
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023	Mar. 22	BU
Revelation Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)	Mar. 13	BU
Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference	Mar. 12	BU
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini	Mar. 04	BU
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini	Mar. 04	CI
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)	Feb. 13	BU
Revelation Biosciences : Announces Commencement of First in Human Phase 1 Clinical Study of Gemini	Feb. 12	PU
Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences, or Sunworks?	Feb. 12	PR
Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering	Feb. 05	BU
Top Midday Decliners	Feb. 01	MT
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday on Unchanged Fed Rate, Upcoming Earnings	Feb. 01	MT
Top Premarket Decliners	Feb. 01	MT
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering	Feb. 01	BU
Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?	Jan. 31	PR
Top Premarket Gainers	Jan. 31	MT
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)	Jan. 30	BU
Top Premarket Gainers	Jan. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Revelation Biosciences, Inc.

Equities

REVB

US76135L5075

Summary

Filters